Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes - Wikidata - awgldk - TriplyDB

Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes

Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes

http://www.wikidata.org/entity/Q28361901

about

Renal dopaminergic system: Pathophysiological implications and clinical perspectives Chemistry and antihypertensive effects of tempol and other nitroxides Reciprocal regulation of the nitric oxide and cyclooxygenase pathway in pathophysiology: relevance and clinical implications The complex interplay between cyclooxygenase-2 and angiotensin II in regulating kidney function Nonsteroidal Anti-Inflammatory Drugs and the Kidney A dual COX-2/sEH inhibitor improves the metabolic profile and reduces kidney injury in Zucker diabetic fatty rat Increased expression of cyclooxygenase-1 and -2 in the diabetic rat renal medulla Early degenerative effects of diabetes mellitus on pancreas, liver, and kidney in rats: an immunohistochemical study.Interaction of the renin angiotensin and cox systems in the kidney.Human glomerular endothelium: interplay among glucose, free fatty acids, angiotensin II, and oxidative stress.Renal hyperfiltration is a determinant of endothelial function responses to cyclooxygenase 2 inhibition in type 1 diabetes.The renal vascular response to diabetes.Upregulation of fibronectin expression by COX-2 is mediated by interaction with ELMO1.Albumin-induced podocyte injury and protection are associated with regulation of COX-2.Renal protective effect of chronic inhibition of COX-2 with SC-58236 in streptozotocin-diabetic rats Glomerular endothelial cell injury and cross talk in diabetic kidney disease COX-2 but not mPGES-1 contributes to renal PGE2 induction and diabetic proteinuria in mice with type-1 diabetes.Endothelium-mediated control of vascular tone: COX-1 and COX-2 products.Renal hyperfiltration related to diabetes mellitus and obesity in human disease.Eicosanoids and renal damage in cardiometabolic syndrome.2-Hydroxyestradiol slows progression of experimental polycystic kidney disease Intrarenal dopamine inhibits progression of diabetic nephropathy.Twenty years after ACEIs and ARBs: emerging treatment strategies for diabetic nephropathy.Hyperfiltration and effect of nitric oxide inhibition on renal and endothelial function in humans with uncomplicated type 1 diabetes mellitus.Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis.Gq-dependent signaling upregulates COX2 in glomerular podocytes.Effects of cyclooxygenase-2 gene inactivation on cardiac autonomic and left ventricular function in experimental diabetes Activation of the succinate receptor GPR91 in macula densa cells causes renin release.Distinct roles for basal and induced COX-2 in podocyte injury Renin inhibition in the treatment of diabetic kidney disease.Pathophysiology of the diabetic kidney.Cyclooxygenase metabolites in the kidney.Podocyte-specific knockout of cyclooxygenase 2 exacerbates diabetic kidney disease.NOD1 receptor is up-regulated in diabetic human and murine myocardium.CYP450, COX-2 and Obesity Related Renal Damage.Reduced IP receptors in STZ-induced diabetic rat kidneys and high-glucose-treated mesangial cells.PGE2 reduces arachidonic acid release in murine podocytes: evidence for an autocrine feedback loop.High ambient glucose augments angiotensin II-induced proinflammatory gene mRNA expression in human mesangial cells: effects of valsartan and simvastatin.Podocyte COX-2 exacerbates diabetic nephropathy by increasing podocyte (pro)renin receptor expression Chronic Administration of Oil Palm (Elaeis guineensis) Leaves Extract Attenuates Hyperglycaemic-Induced Oxidative Stress and Improves Renal Histopathology and Function in Experimental Diabetes.

P2860

Q22241156-B62977D8-AE4F-46AE-B6BD-C96601E01EC3 Q24658069-279CD344-73C9-4557-BA09-72899CFE1BE4 Q26852195-370D6C6E-DF80-4F88-918B-ABEAC993E237 Q26995081-7449E0EB-DE59-4ABF-902F-E19042B00F6F Q28386844-AB42B9CD-718C-415E-B74C-F8E4B6FB49D3 Q28390006-9E3A2760-F378-4395-A7CD-9FE62D67FAD1 Q28577490-A057D92D-5EBE-4BB2-B4A8-B3999B96B5C3 Q29347055-7781B423-DA45-40D7-A45A-184B714B51A3 Q30276943-9E15E15A-F3F9-4D91-A6B2-6B8EA0AC1008 Q33589138-C06880E7-308A-4E48-ADC2-4195B9B94723 Q33873175-C1108D75-0866-42F2-80BE-BB8FEFBAD920 Q33917570-DCF79AC1-F7BD-4D05-8E3C-808C41F1A03C Q34209244-78AD5873-F9A0-49BD-B587-6E9B56544B14 Q34577309-BDD59CC6-0302-4C3F-84BD-3D36420382C1 Q35056916-E3DD7E33-250C-430E-B196-9BE889C43FB8 Q35086477-26A22139-EE74-40C4-A43C-AE34DB899DBC Q35199315-B74B9572-EE36-4354-A6D7-F1F63BE9AF28 Q35376020-FD851EAD-5AA8-4416-ADA0-20D98EB9473A Q35673442-425D81C0-D972-476D-8085-A4FC0C8652E6 Q35947602-FBC8697D-D2B6-404C-B628-B2B1D921C7D7 Q35964504-963A6B3E-137D-4D7E-8F19-675B88D68FA0 Q36249732-BF7FBD44-1FDB-4427-BB65-BC8EECE97E88 Q36297539-AEAC17F3-60C3-40CE-80D8-56717A867901 Q36312587-077D6F8C-C0DA-44D1-B564-E34D656EDFE2 Q36589609-89F92649-D3DB-4F71-877D-0D83C37FB81F Q36949225-7109CFAF-163F-4A43-80EB-A21456CEC037 Q37100174-F62FFF89-CEB1-42A4-9530-688D650B0DED Q37181984-26F6661E-AC1A-460F-BB6C-C86FF500FC36 Q37330528-5B6A1066-62B3-4E00-AE09-A2CE7A939D01 Q38075571-256434F2-F37C-472F-9293-7FB1A4FB1DB5 Q38111707-711EA3B6-E3D2-4CC7-B171-EFD1C35D550D Q38111723-198C6C4E-3C9B-44F5-9796-1C0FA1137315 Q38793769-B1B917F2-5092-48AB-AC97-1CBCBA333EC9 Q38984265-AC995B7F-CA39-4AB1-8F51-E21812874FBF Q40457824-D5B2E1B7-B0BB-419F-BBE6-FBCC8ACCBE0F Q40552294-42BDFA31-D546-40DE-AB70-DE114A833CF4 Q40696301-511D9C23-103D-482C-8220-74FE06A9DF6E Q41807679-91ED3C73-5CB9-4844-AFFB-9CDACB3DE904 Q41998066-77251402-DE7B-4FAC-BD41-03BFF08AEB68 Q42184935-7FB310E5-A396-4064-8198-039947DC4DB7

P2860

Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes

http://www.wikidata.org/entity/Q28361901

description

2001 nî lūn-bûn

@nan

2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Immunohistochemical and functi ...... ase-2 in experimental diabetes

@ast

Immunohistochemical and functi ...... ase-2 in experimental diabetes

@en

Immunohistochemical and functi ...... ase-2 in experimental diabetes

@nl

type

label

Immunohistochemical and functi ...... ase-2 in experimental diabetes

@ast

Immunohistochemical and functi ...... ase-2 in experimental diabetes

@en

Immunohistochemical and functi ...... ase-2 in experimental diabetes

@nl

prefLabel

Immunohistochemical and functi ...... ase-2 in experimental diabetes

@ast

Immunohistochemical and functi ...... ase-2 in experimental diabetes

@en

Immunohistochemical and functi ...... ase-2 in experimental diabetes

@nl

P1433

Q28361901-06DE378A-4235-4158-8AB5-8FA89C1D8D2D

P1476

Q28361901-FFF0E97F-D862-4EEF-80D2-B5B14B7B097D

P2093

Q28361901-281C286B-5239-48E5-AF4A-E77F1B51B268

Q28361901-2947A5EC-5051-4A7C-AF6E-9A384DC12E03

Q28361901-3621C8C7-7A2E-46DA-A2D8-7A8B84147EB2

Q28361901-623219EE-67AD-4AC7-B986-5B26C79AA325

Q28361901-997A98BB-12E1-4420-94CE-79F0272AF955

Q28361901-C1EF827E-3CC7-4FEB-B882-DFCE621B2005

Q28361901-FCDFD0AA-FB74-4B09-AC0A-4B2F67A63DAD

P2860

Q28361901-0B6E6A27-BE13-44E1-897C-F1F1FAF42837

Q28361901-0C0889D0-2C5F-4F16-B76C-4B5E139B1404

Q28361901-232F8FAF-0C7B-4867-A790-E9590EB3CD6C

Q28361901-299BCD6F-583B-4667-9B8B-06FA7E38B8E1

Q28361901-3C1608EF-4DF4-4A00-8471-FE52F07E388B

Q28361901-3C227BC4-6133-40FA-BF8C-F3318BDB5A9F

Q28361901-4486D1F0-39C7-41A8-8C48-57ACCD77BA9B

Q28361901-4F03004F-8A80-4627-BFB6-36F1993D8835

Q28361901-4F849367-901B-494D-B910-B660B7A4F1D0

Q28361901-51D0F030-3714-415D-8D33-9EA6502CB063

P304

Q28361901-7149FDDE-3833-4421-B068-EF0D2EB6EE2C

P31

Q28361901-10497C5D-E554-4314-90E4-6FE90B6BDA1A

P356

Q28361901-49FD5781-770D-4C86-B375-4BE2A286A27D

P407

Q28361901-533BB9A2-C977-45E5-BC0F-23037BF97D3D

P433

Q28361901-38ABAF06-7746-4595-AAF5-EE14903D6D0B

P478

Q28361901-DFB97D84-A636-4F46-871E-402707F7A2E5

P577

Q28361901-15F2CC84-3E26-4F11-B28C-106DEB7827E1

P698

Q28361901-40A8FE5F-C222-4389-9982-2531D9D83EE2

P921

Q28361901-ECF4B817-84AF-4328-9B1D-6771195BFD76

P932

Q28361901-E8F89304-7BF9-4038-B8B0-6DEFE210306A

P356

P1433

Journal of Clinical Investigation

P1476

Immunohistochemical and functi ...... ase-2 in experimental diabetes

@en

P2093

J F Reed

http://www.w3.org/2001/XMLSchema#string

J N Lindsley

http://www.w3.org/2001/XMLSchema#string

R Komers

http://www.w3.org/2001/XMLSchema#string

S Anderson

http://www.w3.org/2001/XMLSchema#string

S L Mader

http://www.w3.org/2001/XMLSchema#string

T T Oyama

http://www.w3.org/2001/XMLSchema#string

W E Schutzer

http://www.w3.org/2001/XMLSchema#string

P2860

Angiotensinogen and AT(1) antisense inhibition of osteopontin translation in rat proximal tubular cells

Tubular sodium handling and tubuloglomerular feedback in experimental diabetes mellitus

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2-selective inhibition.

Angiotensin II attenuates renal cortical cyclooxygenase-2 expression.

Glucose-induced protein kinase C activity regulates arachidonic acid release and eicosanoid production by cultured glomerular mesangial cells.

Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase.

Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus

Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.

Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass

P304

889-98

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI10228

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P577

2001-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11285308

http://www.w3.org/2001/XMLSchema#string

P921

immunohistochemistry

P932

199567

http://www.w3.org/2001/XMLSchema#string